Loading...
Leukemia Lymphoma Scholarships2018-05-30T09:17:13+00:00

SCHOLARSHIP WINNERS

The Jackie Spellman Scholarship Foundation is proud to honor Jackie’s memory by providing scholarships to deserving students whose lives have been impacted by leukemia and lymphoma. To date, our foundation has awarded 96 scholarships totaling $348,000!

Unfortunately, we cannot help everyone who applies but we are grateful to everyone who takes the time to complete an application and/or support our efforts.

2017 Winners

2016 Winners

2015 Winners

2014 Winners

2013 Winners

2012 Winners

2011 Winners

APPLICATION INFORMATION

The Jackie Spellman Scholarship Foundation is proud to honor Jackie’s memory by providing scholarships to deserving students whose lives have been impacted by leukemia and lymphoma. To date, our foundation has awarded 96 scholarships totaling $348,000!

Unfortunately, we cannot help everyone who applies but we are grateful to everyone who takes the time to complete an application and/or support our efforts.

The Jackie Spellman Scholarship is open to U.S. citizens who have been impacted in some way by leukemia or lymphoma, either as survivors, individuals diagnosed with leukemia or lymphoma, or individuals who have a member of his or her immediate family who have or had leukemia or lymphoma while living in the same household. Eligible students include high school seniors or those attending community college, a four-year university or graduate school.

Applicants must meet all criteria established by the application process.* Students majoring in health or nursing related majors may receive priority.

Note: ONLY SCHOLARSHIP WINNERS WILL BE NOTIFIED.

*Each scholarship awarded to a recipient is awarded for undergraduate and graduate studies at an accredited college or university, as defined in section 170(b)(1)(A)(ii). The scholarship funds will be paid directly to the college or university for tuition and fees. Any unused funds must be distributed back to the Foundation.

The 2019 application will be available mid-December 2018